SynthesisFrontiers in endocrinology2023

Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials.

Rui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.